In our previous publication [9], we described that a mixture of two peptides (APP1 390–412 and Tau1 19–34) prevents the association of the two brain proteins APP and Tau and improves the cognitive ability in a transgenic mouse model of AD. Here, MAPT is linked to Alzheimer disease.